Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $2.1 million.

  • Legend Biotech's Depreciation and Depletion fell 986.98% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 1148.55%. This contributed to the annual value of $10.7 million for FY2024, which is 3.74% down from last year.
  • Latest data reveals that Legend Biotech reported Depreciation and Depletion of $2.1 million as of Q3 2025, which was down 986.98% from $2.3 million recorded in Q2 2025.
  • Legend Biotech's Depreciation and Depletion's 5-year high stood at $3.2 million during Q1 2022, with a 5-year trough of -$20000.0 in Q4 2021.
  • In the last 5 years, Legend Biotech's Depreciation and Depletion had a median value of $2.7 million in 2023 and averaged $2.4 million.
  • Within the past 5 years, the most significant YoY rise in Legend Biotech's Depreciation and Depletion was 1250500.0% (2022), while the steepest drop was 3892.57% (2022).
  • Legend Biotech's Depreciation and Depletion (Quarter) stood at -$20000.0 in 2021, then soared by 12505.0% to $2.5 million in 2022, then grew by 9.88% to $2.7 million in 2023, then rose by 0.62% to $2.7 million in 2024, then fell by 21.76% to $2.1 million in 2025.
  • Its Depreciation and Depletion stands at $2.1 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.3 million for Q1 2025.